Clin2
NCT07054099Possibly a fitRecruiting

Testing a chickenpox vaccine for children ages 1 to 12

Varicella (Chickenpox)Chickenpox Vaccine

Treatments studied

Part of Infections clinical trials.

This study tests a new chickenpox vaccine (MG1111, also called BARYCELA Inj.) in healthy children aged 1 to 12 years. It checks how well the vaccine works and if it is safe, with two doses given over time.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
474 people
Ages
1 year to 12 years
Study type
Interventional

Who can take part

  • Your child must be between 12 months and 12 years old.
  • Your child must be generally healthy.
  • Your child must not have had chickenpox or any chickenpox vaccine before.
  • Your child must not have had close contact with someone with chickenpox in the 4 weeks before screening.
  • Your child must not have a moderate or severe infection (with or without fever) at the time of vaccination.
  • Your child must not have had any allergic reaction symptoms (like a rash) in the 72 hours before each vaccine dose.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07473427Not yet recruiting· Phase 3
Chickenpox vaccine study for healthy children aged 1 to 12

This study tests a chickenpox (varicella) vaccine in healthy children to see how well it works and if it is safe. It may help protect your child from chickenpox.

Hanoi
NCT07415252Recruiting· Phase 3
Chickenpox vaccine study for healthy children aged 12 months to 12 years

This study tests a chickenpox vaccine in healthy children. It aims to see if a lower dose of the vaccine is as effective and safe as the standard dose. Your child may be able to join if they have never had chickenpox or the vaccine.

San Pedro Sula, Cortés Department
NCT07475000Recruiting· Phase 3
Second chickenpox vaccine for healthy children

This trial is testing a second dose of the chickenpox vaccine in healthy children who already received one dose. It aims to see if a booster dose provides better protection.

Akdeniz
NCT07742644Not yet recruiting· Phase 3
Combined MMR and chickenpox booster for children

This study tests a combined one-shot vaccine for measles, mumps, rubella, and chickenpox in healthy children aged 4 to 6 who've already had their first shots. It aims to see if this new combination vaccine is as effective and safe as giving separate boosters.

Jonesboro, Arkansas
NCT06891872Not yet recruiting· Phase 4
Chickenpox vaccine with routine toddler shots

This study tests whether giving the chickenpox vaccine at the same time as the MMR and DTaP vaccines is safe for toddlers. Your child may get extra protection with fewer doctor visits.

Chongqing
NCT05422508Recruiting· Phase 2
Second chickenpox shot for healthy kids after one prior vaccine

This study gives a second chickenpox vaccine dose to healthy children who were vaccinated once before. It mainly checks safety and measures the body’s immune response to see how well the second dose works.

Ansan

Hear when a new Varicella (Chickenpox) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.